GenVec vs Vertex Pharmaceuticals Incorporated
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Vertex Pharmaceuticals Incorporated had more revenue: $12.0 B in the year to December 2025 against $1 M for GenVec in the year to December 2016.
- Vertex Pharmaceuticals Incorporated made a net profit of $4.0 B, while GenVec made a net loss of $6 M.
- Vertex Pharmaceuticals Incorporated keeps more of each dollar of sales: a net margin of 32.9% against -1135.3% for GenVec.
- Vertex Pharmaceuticals Incorporated employs more people: 6,400 against 15 at GenVec. Each employee brings in about $34,000 of revenue at GenVec and $1,875,203 at Vertex Pharmaceuticals Incorporated.
Market cap history
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | GenVec GNVC | Vertex Pharmaceuticals Incorporated VRTX · #171 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 1989 |
| Size | ||
| Market cap | — | $134.3 B |
| Revenue | $1 M | $12.0 B |
| Net income | $-6 M | $4.0 B▲ best |
| Employees | 15 | 6,400 |
| Valuation | ||
| P/E ratio | — | 33.8× |
| Price to sales | — | 10.4× |
| Price to book | — | 7.2× |
| Free cash flow yield | — | 2.4% |
| Profitability | ||
| Gross margin | — | 86.2% |
| Operating margin | — | 34.8% |
| Net margin | — | 32.9% |
| Return on equity | — | 22.5% |
| Return on invested capital | — | 26.2% |
| Growth | ||
| Revenue growth | — | 8.9% |
| Revenue growth, 3 years a year | — | 10.3% |
| Financial strength | ||
| Debt to equity | — | 0.0× |
| Net debt to EBITDA | — | -1.2× |
| Cash | ||
| Free cash flow margin | — | 26.6% |
| Shareholder returns | ||
| Shareholder yield | — | 1.5% |
| Altman Z-score zone | — | safe |
| Data as of | Market cap — | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which makes more money, GenVec or Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated had more revenue: $12.0 B in the year to December 2025 against $1 M for GenVec in the year to December 2016. Vertex Pharmaceuticals Incorporated made a net profit of $4.0 B, while GenVec made a net loss of $6 M.
Which is more profitable, GenVec or Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated keeps more of each dollar of sales: a net margin of 32.9% against -1135.3% for GenVec.
Which has more employees, GenVec or Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated employs more people: 6,400 against 15 at GenVec. Each employee brings in about $34,000 of revenue at GenVec and $1,875,203 at Vertex Pharmaceuticals Incorporated.
More about GenVec
More about Vertex Pharmaceuticals Incorporated
- Vertex Pharmaceuticals Incorporated: company page
- Who owns Vertex Pharmaceuticals Incorporated?
- Vertex Pharmaceuticals Incorporated market cap history
- Vertex Pharmaceuticals Incorporated revenue by year
- How many employees does Vertex Pharmaceuticals Incorporated have?
- Is Vertex Pharmaceuticals Incorporated cheap or expensive?
- Vertex Pharmaceuticals Incorporated against its peers: ranks and percentiles
Sources#
Every figure on this page comes from these, with the date shown next to it.